arrow
T

Théo Z. Hirsch

Sorbonne Universite
H指数:20
被引数:1,979

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated genomic analyses identify oncogenic pathway interplay in hepatocarcinogenesis defining specific molecular subtypes

整合基因组分析识别肝细胞癌发生中定义特定分子亚型的致癌通路相互作用

2026-05-190
OAAI
Molecular evolution of mosaic chromosome 18 copy-number alterations from gametes to hepatoblastoma

嵌合染色体18在配子到肝母细胞瘤过程中的分子进化及拷贝数改变

2026-04-200
OAAI
Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma

血清降钙素原: 诊断和监测纤维板层肝癌的新型肿瘤生物标志物

2026-02-060
PRE
Targeting ATR to overcome cisplatin resistance in hepatoblastoma

靶向ATR以克服肝母细胞瘤对顺铂的耐药性

2025-11-290
PRE
Development of mutated β-catenin gene signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC

开发突变型β-catenin基因特征以从肝癌患者全转录组及空间转录组数据中识别CTNNB1突变

2024-12-013
OAAI
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma
2024-04-084
OAAI
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival
2024-03-010
OA
Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma

11 p15.5改变的镶嵌细胞在肝母细胞瘤幼儿中的肿瘤前肝脏定植

2023-11-062
OAAI
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target (vol 74, pg 1155, 2021)
2022-05-010
OA
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
2021-07-1436
OAAI
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target

端粒长度是肝细胞癌多样性的关键,端粒酶成瘾是可行的治疗靶点

2021-05-0165
OAAI